Buy Biogen Stock | BIIB Stock Price & Latest News | Public.com
BIIB

Biogen

$0.00 (0.00%)Today
    View Biogen (BIIB) stock trends here

    About BIIB

    Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    8.84
    5.89
    2.95
    0
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    $4.67

    Actual EPS
    Q2 2021

    Stats

    Market Cap$41,25B
    Volume764,77k
    Price-to-Earnings Ratio14.37
    Dividend Rate
    Dividend Yield
    1 Year High$363.92
    1 Year Low$223.25
    Open$270.66
    High$279.09
    Low$270.66

    Buy any stock with any amount of money.

    Download the App
    Download the app